Issue 65, 2023

Vascular disruption agent and phototherapeutic assembled nanoparticles for enhanced tumor inhibition

Abstract

Vascular disruption agent (combretastatin A-4 phosphate) and phototherapeutic (IEICO-4F) assembled nanoparticles (IFC NPs) were prepared for the first time. The IFC NPs have a high photo energy utilization efficiency of up to 96.1%, and could significantly inhibit tumor growth by photodynamic and photothermal therapy enhanced tumor vascular disruption.

Graphical abstract: Vascular disruption agent and phototherapeutic assembled nanoparticles for enhanced tumor inhibition

Supplementary files

Article information

Article type
Communication
Submitted
01 Jun 2023
Accepted
17 Jul 2023
First published
27 Jul 2023

Chem. Commun., 2023,59, 9896-9899

Vascular disruption agent and phototherapeutic assembled nanoparticles for enhanced tumor inhibition

T. Pan, Y. Tang, E. Pang, S. Zhao, C. Yao, B. Wang, X. Song and M. Lan, Chem. Commun., 2023, 59, 9896 DOI: 10.1039/D3CC02647G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements